Author

Roberta Zappasodi

Weill Cornell MedicineORCID 0000-0002-7031-6671Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Amanda W. LundiD· 1 shared Anthony SantellaiD· 1 shared Ashley SchreieriD· 1 shared Eleni Andreopoulou· 1 shared Ellen AckerstaffiD· 1 shared Francesco BallesioiD· 1 shared Giorgia ColomboiD· 1 shared Inna S. SerganovaiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Amanda W. LundORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologybioRxivPreprintFeb 24, 2026

A tumor metabolism-angiogenesis-immune axis governs immunotherapy responses

Inna S. Serganova, Giorgia Colombo, Francesco Ballesio…·Roberta Zappasodi

This study shows that reducing tumor glycolysis improves immunotherapy responses by normalizing the tumor microenvironment and enhancing immune cell activity.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky